Pharma Litigator Leaves Fitzpatrick Cella, Joins Sidley

Law360, New York (February 22, 2005, 12:00 AM EST) -- Pharma and biotech patent litigator Thomas Beck has left Fitzpatrick Cella Harper & Scinto to join Sidley Austin Brown & Wood LLP as a partner.

Beck, who had been a partner with Fitzpatrick Cella, will continue to focus on complex pharmaceutical and biotechnology patent litigation matters at his new firm’s New York office, Sidley said.

“A lawyer with Tom’s combination of extensive patent litigation experience and keen knowledge of intricate biological and chemical processes is uncommon, and we are delighted that he will bring them to...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.